Material
Umbilical cord blood (UCB) is increasingly used as a source of hematopoietic progenitor cells to treat a variety of disorders. UCB transplant is associated with comparatively reduced incidence of graft-versus-host disease, robust graft versus leukemia effect, and relatively high incidence of opportunistic infections, three processes in which donor-derived T lymphocytes are known to be predominantly involved. To examine the differential functionality of UCB T cells, CD8 + T cells specific for the melanoma-associated HLA-A2-restricted Melan-A [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] A27L peptide were isolated from HLA-A2 + and HLA-A2 2 UCB samples and HLA-A2 + and HLA-A2 2 adult peripheral blood using A2/Melan-A tetramers. In UCB samples, A2/Melan-A + CD8 + T cells were detected at a frequency of 0.04%, were more frequent in HLA-A2 + UCB, and were polyclonal and mostly naive. Consistent with Ag-driven expansion, the frequency of A2/Melan-A + CD8 + T cells was increased following stimulation with cognate peptide or polyclonal activation, they acquired cell-surface markers reflective of effector/memory differentiation, their TCR repertoire became oligoclonal, and they expressed cytolytic activity and produced IFN-g. Although functional properties of A2/Melan-A + CD8 + T cells derived from HLA-A2 + UCB resembled those of HLA-A2 + adult peripheral blood, they were more likely to reach terminal differentiation following polyclonal stimulation and produced less IFN-g in response to cognate peptide. A2/Melan-A + CD8 + T cells from HLA-A2 2 UCB
were poorly cytolytic, produced little IFN-g, and were predominantly monofunctional or nonfunctional. These properties of UCBderived CD8 + T cells could contribute to the reduced incidence of graft-versus-host disease and heightened incidence of opportunistic infections observed following UCB transplant. The Journal of Immunology, 2010, 185: 856-866.
F ollowing hematopoietic stem cell (HSC) transplant, donorderived T lymphocytes play a key role in the pathogenesis of graft-versus-host disease (GVHD) (1) . In addition, until immune reconstitution is achieved, protective antiviral and antitumoral immune responses in the host largely depend on the activity of postthymic T cells that are infused with the HSC grafts (1, 2).
Unrelated umbilical cord blood (UCB) is increasingly being used as a source of cells for patients in need of HSC transplant (3) . In comparison with other HSC sources such as bone marrow or peripheral blood, UCB transplant (UCBT) is characterized by a lower incidence and severity of GVHD, a robust graft versus leukemia effect, but a relatively high incidence of opportunistic infections (OIs) that represent the most important cause of mortality in graft recipients during the first 6 mo posttransplant (4, 5) . These differences in clinical outcome raise important questions regarding the phenotype and functional properties of UCB-derived T lymphocytes. On the one hand, as compared with T cells isolated from adults, UCB T cells have long been considered immature based on their reduced capacity for Th1/Tc1 cytokine production and diminished cytolytic activity (6) (7) (8) (9) . On the other hand, neonatal T cells can mediate alloreactivity (10) and mount efficient antiviral immune responses against CMV, influenza virus, and HIV-1, indicating that they can exhibit functional properties in some settings (11, 12) . Indeed, to this day, there is a paucity of data on the differential functionality of preimmune Ag-specific CD8 + T cells in UCB as compared with adult peripheral blood (AB). CD8 + T cells that recognize the Melan-A [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] A27L peptide presented in the context of HLA-A2 can be isolated from peripheral blood and UCB (13) . These cells are thought to represent the only preimmune T cell repertoire that can be studied in humans (14) . Interestingly, A2/Melan-A + T cells can be reproducibly isolated from blood samples derived from HLA-A2 2 subjects, providing an opportunity to compare T cell responses directed against HLAidentical and HLA-disparate targets (15) . In this study, approaches based on peptide-MHC tetramers were used to characterize the phenotype and immunologic properties of Melan-A-specific CD8 + UCB exhibited properties that were similar to those observed in HLA-A2 + AB but were more likely to achieve terminal differentiation following polyclonal activation and produced significantly less IFN-g on a per-clone basis. In contrast, A2/Melan-A + CD8 + T cells from HLA-A2 2 UCB were comparatively less cytolytic, produced less IFN-g, and were more likely to be monofunctional or nonfunctional. Table I ).
Materials and Methods

Procurement of UCB and AB samples
Generation of T cell microcultures
Frozen UCBMCs were thawed and cultured for 24 h in RPMI 1640 supplemented with 20% v/v FBS. Cells were seeded at 1000 cells/well in 96-well round-bottom plates and were cocultured with 8 3 10 4 irradiated (300 Gy) 221.A2 cells (EBV-transformed B lymphoblastoid cell line expressing HLA-A2 p 0201; kindly provided by Cassian Yee, University of Washington, Seattle, WA) (16) pulsed with the HLA-A2-restricted modified Melan-A [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] A27L peptide (ELAGIGILTV) (Peptide Synthesis Core Facility, Centre Hospitalier de l'Université Laval, Quebec City, Quebec, Canada). T cell microcultures were maintained in RPMI 1640 supplemented with 10% v/v FBS, 50 UI/ml recombinant human (rh)IL-2 (Hoffmann-La Roche, Mississauga, Ontario, Canada), and 10 ng/ml rhIL-7 (R&D Systems, Minneapolis, MN). Medium was replenished biweekly. Effector cells were restimulated weekly for 3 wk with irradiated, peptide-pulsed 221.A2 cells.
Immunophenotyping, peptide-MHC tetramer staining, and cell sorting
Multiparameter fluorescence-activated cell sorting was performed on thawed UCBMCs. A minimum of 1 3 10 5 CD8 + T cells was analyzed. To detect Melan-A-specific T cells in UCBMCs, T cell microcultures, and expanded T cell clones, biotinylated HLA-A2 monomers were refolded around Melan-A 26-35 A27L or CMVpp65 (NLVPMVATV) peptides (CANVAC, Montreal, Quebec, Canada) and were tetramerized using PEconjugated extravidin (Sigma-Aldrich, St. Louis, MO) or allophycocyaninconjugated streptavidin (BD Biosciences, San Jose, CA). The following mAbs were used: Alexa 700-conjugated anti-CD3 (UCHT1), Pacific Blueconjugated anti-CD8 (RPA-T8), PE-Cy7-conjugated anti-CCR7 (3D12), PE-conjugated or APC-conjugated anti-CD27 (M-T271), and FITCconjugated anti-CD45RA (HI100) (BD Biosciences). UCBMCs, in vitrogenerated T cell microcultures, or expanded T cell clones were incubated for 15 min at 37˚C with 0.3 mg peptide-MHC tetramers/1 3 10 6 cells. mAbs for cell-surface staining were then added, and cells were incubated for 30 min at room temperature. Tetramer-specific CD8 + cells were sorted at low pressure in 100% v/v FBS using an FACSAria flow cytometer equipped with FACSDiva software (BD Biosciences). Compensation was performed with single fluorochromes and CompBeads (BD Biosciences). Logical gates were set using fluorescence-minus-one controls. Lymphocytes were gated according to forward/side scatter. Melan-A-specific T cells were gated based on expression of CD3 and CD8 (17) . Analysis of cell-surface markers was performed using FCS Express Version 3 software (De Novo Software, Los Angeles, CA).
Expansion of sorted T cells
Tetramer-sorted T cells from UCB or AB were directly seeded at 1-3 cells/well in 96-well round-bottom plates and were cocultured with 8 3 10 4 irradiated (300 Gy) 221.A2 cells/well in RPMI 1640 supplemented with 50% v/v FBS, 50 UI/ml rhIL-2, and 1 mg/ml PHA (Sigma-Aldrich). After 48 h, medium was replaced with RPMI 1640 supplemented with 20% v/v FBS, 50 UI/ml IL-2, 1 mg/ml PHA, and 10 ng/ml IL-7 (16). Medium was changed every 2 to 3 d, and 2 3 10 4 irradiated 221.A2 cells/well were added once a week for 3 wk.
Cytotoxicity testing
Cytolytic activity of T cell microcultures and expanded T cells was measured using a conventional 4-h [ 51 Cr] release assay (18) . 51 Cr-labeled targets were 221.A2 cells pulsed with cognate Melan-A 26-35 A27L or control hepatitis C virus NS3-1406 peptide (KLVALGINAV). E:T ratio was 10:1 (2 3 10 3 target cells/well).
ELISPOT IFN-g secretion by T cell microcultures and expanded T cells was measured using ELISPOT (19 
Amplification and sequencing of TCR b-chain transcripts
Total mRNA was extracted from pellets of tetramer-sorted cells (150-1500 cells) using the Picopure system (Molecular Devices, Sunnyvale, CA). The TCR b-chain V region (TRBV) mRNA, including CDR3, was reverse transcribed, and corresponding cDNA was amplified by PCR (40 cycles) using universal primers, as described previously (20) . PCR products were subcloned into the TOPO TA cloning vector (Invitrogen) and sequenced (Centre Hospitalier de l'Université Laval). Identification of TRBVand TCR b-chain J region (TRBJ) segments and determination of CDR3 length and amino acid sequences was performed using IMGT/V-QUEST and confirmed manually (21) .
Statistical analysis
Normality of the distribution of sample data was assessed using the D'Agostino and Pearson normality omnibus test. Statistical significance in betweengroups comparisons was assessed using the Mann-Whitney U test. The x 2 test was used to examine categorical data. Spearman correlation and linear regression analysis were used to test correlations between groups. p values , 0.05 were considered statistically significant. All analyses were performed using GraphPad Prism 4 (GraphPad, San Diego, CA).
Results
Melan-A-specific T cells are detectable in UCB
The presence of Melan-A-specific CD8 + T cells was estimated in UCB (HLA-A2 + , n = 12; HLA-A2 (n = 4) UCB samples as described in Materials and Methods. TRBV usage, TRBJ usage, and CDR3 length were determined using IMGT/V-QUEST (21) . Gaussian distribution of CDR3 length is consistent with a preimmune T cell repertoire.
respectively, but the difference was statistically significant in the case of AB only (p = 0.0580 and p = 0.0415, respectively) (Fig. 1A) .
Melan-A-specific T cells from UCB express a naive phenotype
To gain insight into the differentiation pattern and proliferative history of A2/Melan-A + CD8 + T cells from UCB, cell-surface expression of CD45RA, CCR7, and CD27 was examined, allowing the stratification of CD8 + T cells into six (Fig. 1B, 1C) . Thus, freshly isolated Melan-A-specific CD8 + T cells from UCB are less differentiated than their AB counterparts.
The Melan-A-specific CD8 + T cell repertoire in UCB is polyclonal and highly diversified
To study the diversity and dynamics of the Melan-A-specific CD8 + T cell compartment, the repertoire of TCR b-chain genes expressed by sorted A2/Melan-A + CD8 + T cells was examined using PCR amplification, cloning, and sequencing in absence of in vitro stimulation. This analysis revealed that the clonal diversity of freshly isolated A2/Melan-A + CD8 + T cells was significantly lower in HLA-A2 + than in HLA-A2 2 UCB samples (p = 0.0143) ( Fig. 2A) . Clonal diversity was also examined in terms of TRBV gene usage, TRBJ gene usage, and CDR3 length, which represent three important structural determinants of Ag recognition by the TCR (23) . Though the profiles were similar, TRBV and TRBJ gene usage was broader in A2/Melan-A + CD8 + T cells isolated from HLA-A2
2 UCB samples as compared with those derived from HLA-A2 + UCB samples (Fig. 2B) . In both HLA-A2 + and HLA-A2 2 UCB samples, the distribution of CDR3 lengths in A2/ Melan-A + CD8 + T cells was quasi-Gaussian (p = 0.5680), consistent with a preimmune repertoire (Fig. 2B) (24, 25) . (Fig. 3A) . The overall proportion of CD8 + T cells was also significantly increased (p , 0.0001) (Fig. 3B) . Similar levels of expansion were observed in AB samples (data not shown). In addition, the frequency of A2/Melan-A + CD8
+ T cells following in vitro peptide stimulation was significantly correlated with the proportion of A2/Melan-A + CD8 + T lymphocytes in freshly isolated cell samples (p , 0.0001) (Fig. 3C) .
Next, the diversity of the Melan-A-specific T cell repertoire was examined following stimulation with cognate peptide. Tetramersorted A2/Melan-A + T cells derived from peptide-stimulated UCB microcultures showed significantly lower levels of clonal diversity as compared with freshly isolated A2/Melan-A + T cells (p = 0.0325; HLA-A2 + and HLA-A2 2 samples analyzed together) (Fig. 4A) . In contrast to what was observed in freshly isolated cells (Fig. 2) , clonal diversity was lower in UCB-derived A2/Melan-A + CD8 + T cells isolated from HLA-A2 2 donors as compared with HLA-A2 + donors, though not significantly so (p = 0.125) (Fig. 4B ). TRBV3-1, TRBV5-6, and TRBV9 accounted for 81.0% of total TRBV usage in sequences derived from HLA-A2 + UCB samples, whereas TRBV11-2 accounted for 64.0% of TRBVusage in sequences derived from HLA-A2 2 UCB samples (Fig. 4C) . TCR usage in terms of CDR3 length distribution was narrower postculture in T cell microcultures derived from both HLA-A2 + and HLA-A2 2 UCB samples (Figs. 2B, 4C ). These results demonstrate that A2/ Melan-A + CD8 + T cells can undergo oligoclonal expansion following stimulation with cognate peptide, irrespective of whether they were derived from HLA-A2 + or HLA-A2 2 UCB.
Differentiation and Ag-specific cytotoxic activity of UCB-derived Melan-A-specific T cells
As A2/Melan-A + CD8 + T cells underwent oligoclonal expansion following stimulation with cognate peptide, it was important to assess whether this proliferation was accompanied by phenotypic (Fig. 5A) . Similarly, in HLA-A2
2 UCB samples, a mean of 53.5 6 3.35% of peptide-stimulated A2/Melan-A + CD8 + T cells remained naive, whereas others differentiated into EMRA (37.2 6 1.13%) and EMRA-E (6.30 6 1.6%) (Fig. 5A) .
In (Fig. 6A) . Furthermore, the median percent specific cytotoxicity was higher in T cell microcultures derived from HLA-A2 (Fig. 6B) . Cytolytic activity was also measured in tetramer-sorted A2/Melan-A + CD8 + T cell clones following PHA-driven expansion; again, the median frequency of cytolytic T cell clones was equivalent between HLA-A2 + UCB-and HLA-A2 + AB-derived microcultures and was lower in HLA-A2 2 samples as compared with HLA-A2 2 AB samples (p = 0.0028). Of note, the median frequency of cytolytic T cell clones was higher in HLA-A2 + UCB samples as compared with HLA-A2 2 UCB, but this difference did not reach statistical significance (p = 0.1112) (Fig. 6C) . Likewise, median specific cytolytic activity was similar between HLA-A2 + UCB samples and HLA-A2 + AB samples (p = 0.2956) and lower in A2/Melan-A + T cell clones derived from HLA-A2
2 UCB donors as compared with clones derived from HLA-A2 2 AB (p = 0.0094) (Fig. 6D) . These results indicate that the cytolytic activity of HLA-A2 + UCB-derived Melan-A-specific T cells is equivalent to that of AB-derived T cells, whereas the cytolytic activity of Melan-A-specific T cells derived from HLA-A2
2 UCB is comparatively impaired. 
Melan-A-specific UCB-derived T cells can specifically secrete IFN-g
To further characterize the functionality of A2/Melan-A + T cells from UCBMCs, production of IFN-g by expanded A2/Melan-A + CD8 + T cell clones was examined using ELISPOT. 2 AB were monofunctional (Fig. 7B) .
Overall, the polyfunctionality profile expressed by HLA-A2 + UCB T cells significantly differed from that expressed by HLA-A2 2 UCB T cells and HLA-A2 + AB T cells (p , 0.0001 in both cases). In contrast, the polyfunctionality profiles displayed by HLA-A2 2 UCB T cells did not significantly deviate from that of HLA-A2 2 AB T cells (p = 0.8220). These data demonstrate that a proportion of Melan-A-specific T cells derived from HLA-A2 + UCB exhibit bifunctional properties following polyclonal expansion, though this proportion is lower than that observed in HLA-A2 + AB-derived Melan-A-specific T cells. Furthermore, when evaluation was made on a per-sample basis, expanded A2/Melan-A + CD8 + T cells were less likely to be nonfunctional and more likely to be monofunctional when they were derived from HLA-A2 + UCB as compared with HLA-A2
2 UCB (p = 0.0082 and p = 0.0115, respectively).
However, on a per-sample basis, the likelihood of expanded A2/ Melan-A + CD8 + T cells to be bifunctional was not significantly different whether they were derived from HLA-A2 + or HLA-A2 2 UCB (Fig. 7C ).
Discussion
In this report, the functionality of UCB-derived Ag-specific and alloreactive T cells was studied to revisit the so-called immaturity of this T cell subset and provide a rationale for the reduced incidence of GVHD and higher incidence of OIs following UCBT. Using peptide-MHC tetramers, Melan-A-specific CD8 + T cells were detected in HLA-A2 + UCB at a frequency noninferior to that , and IL-7 as described in Materials and Methods. After 2 wk in culture, wells were pooled, and 1 3 10 6 live cells were gated based on forward and side scatter. Cell-surface phenotype of A2/ Melan-A + T cells was determined on pooled microcultures using flow cytometry. Naive, CM, EM (EM 1-2 , EM 3-4 ), effector (EMRA-pE 1 and EMRA-pE 2 ), and terminally differentiated effector (EMRA-E) phenotypes were defined based on cell-surface expression of CD45RA, CCR7, and CD27 as described (22) . B, UCBMC sorted using Melan-A 26-35 A27L-HLA-A2 tetramers were seeded (1-3 cells/well) onto allogeneic feeder cells and incubated in the presence of PHA, IL-2, and IL-7 as described in Materials and Methods. After 2 wk in culture, 1 3 10 5 live cells were gated based on forward and side scatter for each microculture that was analyzed (23 microcultures for 11 UCB samples). Cell-surface phenotype was analyzed as above. C, AB-derived T cells sorted using Melan-A 26-35 A27L-HLA-A2 tetramers were seeded (1-3 cells/well) onto allogeneic feeder cells and incubated in the presence of PHA, IL-2, and IL-7. After 2 wk in culture, 1 3 10 5 live cells were gated based on forward and side scatter for each microculture that was analyzed. Cell surface phenotype was analyzed as above. n represents the number of UCB or AB samples that were used in the generation of T cell microcultures. Cytolytic activity and IFN-g production were measured as described in Materials and Methods. Percent specific cytotoxicity was computed as [(sample release 2 spontaneous release) 3 100/ (maximal release 2 spontaneous release)]. For spontaneous release, targets were plated without T cells. For maximum release, targets were plated with 10% v/v Triton X-100. Samples were considered positive when specific cytotoxicity measured in presence of cognate peptide was .10% and .2 SD above cytotoxicity measured in absence of peptide. IFN-g production was expressed as SFUs. Cells incubated with complete medium alone were used as negative controls. Samples were considered positive when SFUs measured in presence of cognate peptide were .20 and .2 SD above SFUs measured in absence of cognate peptide. Upper cutoff was 400 SFU per well. All tests were performed in duplicate. A, Relative frequencies of CD8 + T cell microcultures derived from HLA-A2 + UCB (n = 10), HLA-A2 2 UCB (n = 8), HLA-A2 + AB (n = 4), and HLA-A2 2 AB (n = 4) that exhibited Melan-A-specific cytolytic activity following a 2-wk stimulation with (27) .
T cells from UCB were previously shown to exhibit impaired proliferative capacity (6) (7) (8) (28) (29) (30) . In sharp contrast, results presented in this study demonstrate for the first time that the A2/ Melan-A + CD8 + T cell subsets isolated from HLA-A2 + UCB are able to expand significantly following stimulation with cognate peptide. Expanded T cell populations became oligoclonal and exhibited biased TRBV and TRBJ gene usage, as well as a restricted distribution of CDR3 length. These markers of Agdriven T cell expansion were observed in multiple studies of functional T cell responses to pathogens and tumors (20, 24, 31) . Following UCB stimulation with cognate peptide, ∼50% of A2/ Melan-A + CD8 + T cells acquired an EM or EMRA phenotype, and a minority became terminally differentiated. In contrast, expansion of UCB-derived A2/Melan-A + CD8 + T cell clones with PHA led a larger proportion to differentiate into EMRA-E as compared with AB, in which only few T cell clones became fully differentiated EMRA-E. This was observed in both HLA-A2 + and HLA-A2 2 UCB and AB samples. This indicates that CD8 + T cells from UCB can differentiate following polyclonal stimulation. Moreover, they attain terminal differentiation faster and/or more directly than AB-derived CD8 + T cells, irrespective of the starting proportion of naive T cells in AB. Similar observations were previously reported with UCB-derived CD4 + T cells (32) . Alternatively, these observations could be explained by: 1) differing cellular subtype compositions of starting T cell populations in UCB versus AB; 2) different numbers of cycles of proliferation in UCB versus AB-derived A2/Melan-A + T cells (33) ; and/or 3) differing rates of apoptosis in UCB versus AB-derived A2/Melan-A + T cells (34) . It is worth mentioning that T lymphocytes were cultured in the presence of IL-7, which promotes the survival of neonatal T cells (35) . In theory, this peculiar property of UCB-derived CD8 + T cells could contribute to the reduced incidence and severity of GVHD observed following UCBT as compared with transplants that used other HSC sources (4, 5) .
UCB T cells were traditionally described as nonfunctional, immature, and susceptible to apoptosis (6, 8, 34) . It was proposed that naive UCB T lymphocytes became biased toward Th2 in utero by placenta-derived factors (IL-4, IL-10, TGF-b, PGE 2 ) that are thought to be involved in the maintenance of pregnancy (36) . The relative cytolytic inefficacy of UCB T cells was associated with reduced expression of granzymes and perforin (28, 37) . Costimulation mediated via NKG2D and TLRs was recently shown to be involved in the functional responsiveness of UCB-derived CD8 + T cells (38, 39 ). In the current study, the frequency of T cell microcultures derived from HLA-A2 + UCB that exhibited cytolytic activity in response to cognate peptide was similar to that observed in HLA-A2 + AB. (40) , than their UCB-derived counterparts. Aberrant production of the Th2 cytokine IL-13 and reduced levels of NFAT-1 in UCB T cells was shown to be associated with low levels of IFN-g production (41, 42) . Close examination of cytolytic activity and IFN-g production revealed that HLA-A2 + UCB T cells were more likely to be monofunctional and HLA-A2 + AB T cells more likely to be bifunctional, underscoring the notion that UCB-derived T cells exhibit attenuated, perhaps suboptimal, responses to cognate Ag. These differences could be linked to maturational stage (differential granzyme and/or perforin expression) or differential sensitivity to Ag, which can vary by orders of magnitude in T cells that recognize identical peptide-MHC complexes (43, 44) . In antiviral CD8 + T cell responses, functional avidity for Ag is intimately associated with polyfunctionality (44) (45) (46) . As donor-derived CD8 + T cells play a key role in antiviral and antitumoral immunity in HSC transplant recipients (1, 2), reduced polyfunctionality of UCB-derived CTL might contribute to the higher incidence of OIs, in particular varicella zoster virus infection, that was reported in children following UCBT relative to recipients of bone marrow transplants (5) . Functional impairment should also be taken into consideration when attempting to mobilize virus-specific CTL from UCB for use in the prevention and/or treatment of viral diseases following UCBT (47 (15) . Although differential expression of cytotoxic granule components was not examined in the current study, it is well established that differences in effector functions are reflected by the expression of distinct combinations of intracellular molecules associated with cell-mediated cytolytic activity (50) (51) (52) . Indeed, the multifunctionality profile expressed by A2/Melan-A + CD8 + T cells from HLA-A2
2 UCB markedly differed from that expressed by T cells from HLA-A2 + UCB: the former were more likely to be nonfunctional, whereas the latter were more likely to be mono-or bifunctional. This difference is unrelated to differentiation, because A2/Melan-A + cells from HLA-A2 + and HLA-A2 2 UCB display quasi-identical naive-effector-memory population structures. As functional avidity is closely associated with cytolytic activity, rapid proliferation of high avidity A2/Melan-A + CD8 + T cells from HLA-A2 2 UCB could have led to clonal exhaustion, consistent with the reduced frequency of cytolytic T cells that was observed following peptide stimulation or polyclonal activation. Alternatively, it is possible that tetramer staining by itself led to clonal deletion of high-affinity A2/ Melan-A + CD8 + T cells from HLA-A2 2 UCB, as highly Agsensitive CTL can be killed by A2/Melan-A tetramers (53, 54) . These two models are compatible with the lower levels of clonal diversity that were observed in expanded A2/Melan-A + CD8 + T cells isolated from HLA-A2 2 UCB following stimulation with cognate peptide. Taken together, these results underscore fundamental differences between A2/Melan-A + CD8 + T cells from HLA-A2 + and HLA-A2 2 UCB in terms of antigenic specificity, activation threshold, and function. In summary, functional properties of UCB-derived Ag-specific CD8 + T cells that were documented for the first time in the current study (differentiation geared toward EMRA-E, reduced frequency of cytolytic and IFN-g-producing T cell clones, and differential polyfunctionality profiles) provide new insights into UCB immunobiology and offer a rationale for the higher incidence of OIs and comparatively low rates of acute and chronic GVHD observed following UCBT, particularly in the face of HLA mismatch (55, 56) . As components of posttransplant immunotherapeutic regimens, UCB-derived CD8 + T cells could potentially be used to alleviate unfavorable outcomes associated with UCBT, including failure of engraftment, leukemic relapse, GVHD, and OIs.
